We also show that pharmacological inhibition of MEK by selumetinib significantly decreased spheroid growth (Fig. 7A,B) and stemness (Fig. 7C,D) in both furin expressing and knockdown cells, showing the role of MEK/ERK signaling pathway in furin mediated cancer stemness maintenance. This evidence concerns the gene MAP2K7 and cancer.